VallesiachotamineCAS# 5523-37-5 |
2D Structure
- Isovallesiachotamine
Catalog No.:BCN3549
CAS No.:34384-71-9
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 5523-37-5 | SDF | Download SDF |
PubChem ID | 5315168 | Appearance | Powder |
Formula | C21H22N2O3 | M.Wt | 350.4 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | methyl (2S)-2-[(E)-1-oxobut-2-en-2-yl]-1,2,6,7,12,12b-hexahydroindolo[2,3-a]quinolizine-3-carboxylate | ||
SMILES | CC=C(C=O)C1CC2C3=C(CCN2C=C1C(=O)OC)C4=CC=CC=C4N3 | ||
Standard InChIKey | NTVLUSJWJRSPSM-QOGBKHAWSA-N | ||
Standard InChI | InChI=1S/C21H22N2O3/c1-3-13(12-24)16-10-19-20-15(14-6-4-5-7-18(14)22-20)8-9-23(19)11-17(16)21(25)26-2/h3-7,11-12,16,19,22H,8-10H2,1-2H3/b13-3-/t16-,19?/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Vallesiachotamine exhibits important cytotoxicity toward human melanoma cells by apoptosis and necrosis. |
Vallesiachotamine Dilution Calculator
Vallesiachotamine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.8539 mL | 14.2694 mL | 28.5388 mL | 57.0776 mL | 71.347 mL |
5 mM | 0.5708 mL | 2.8539 mL | 5.7078 mL | 11.4155 mL | 14.2694 mL |
10 mM | 0.2854 mL | 1.4269 mL | 2.8539 mL | 5.7078 mL | 7.1347 mL |
50 mM | 0.0571 mL | 0.2854 mL | 0.5708 mL | 1.1416 mL | 1.4269 mL |
100 mM | 0.0285 mL | 0.1427 mL | 0.2854 mL | 0.5708 mL | 0.7135 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Rolapitant
Catalog No.:BCC6441
CAS No.:552292-08-7
- AP 18
Catalog No.:BCC7634
CAS No.:55224-94-7
- Dexamethasone Sodium Phosphate
Catalog No.:BCC4557
CAS No.:55203-24-2
- Sasapyrine
Catalog No.:BCC4714
CAS No.:552-94-3
- Daidzin
Catalog No.:BCN5891
CAS No.:552-66-9
- Prunetin
Catalog No.:BCN2335
CAS No.:552-59-0
- Eriodictyol
Catalog No.:BCN1209
CAS No.:552-58-9
- Isorhoifolin
Catalog No.:BCN5739
CAS No.:552-57-8
- Paeonol
Catalog No.:BCN5738
CAS No.:552-41-0
- Oxohydrastinine
Catalog No.:BCN3299
CAS No.:552-29-4
- Kaempferol 3-sophoroside-7-glucoside
Catalog No.:BCN7825
CAS No.:55136-76-0
- (S)-3-Carboxy-4-hydroxyphenylglycine
Catalog No.:BCC6607
CAS No.:55136-48-6
- T16Ainh - A01
Catalog No.:BCC6220
CAS No.:552309-42-9
- A-443654
Catalog No.:BCC1321
CAS No.:552325-16-3
- A-674563
Catalog No.:BCC3903
CAS No.:552325-73-2
- Boc-Gln(Xan)-OH
Catalog No.:BCC3385
CAS No.:55260-24-7
- MnTBAP Chloride
Catalog No.:BCC6477
CAS No.:55266-18-7
- Praziquantel
Catalog No.:BCC4829
CAS No.:55268-74-1
- Atractylodin
Catalog No.:BCN6292
CAS No.:55290-63-6
- (Z)-Falcarindiol
Catalog No.:BCN8495
CAS No.:55297-87-5
- Tiamulin
Catalog No.:BCC9179
CAS No.:55297-95-5
- Thonzonium Bromide
Catalog No.:BCC5636
CAS No.:553-08-2
- Xanthyletin
Catalog No.:BCN6722
CAS No.:553-19-5
- Costunolide
Catalog No.:BCN5740
CAS No.:553-21-9
Alkaloids from Tabernaemontana psorocarpa.[Pubmed:17405098]
Planta Med. 1983 Feb;47(2):83-6.
The isolation of the alkaloids from two different samples of stem bark of Tabernaemontana psorocarpa is described. Both samples contained 16-epi-isositsirikine as the major alkaloid but differed from each other in the number and quantity of the other alkaloids. The following minor alkaloids were identified: 12-methoxy-14,15-dehydro-vincamine, Vallesiachotamine, isoVallesiachotamine, tetrahydroalstonine, coronaridine and voacangine.
In vitro antiproliferative effects of the indole alkaloid vallesiachotamine on human melanoma cells.[Pubmed:22477204]
Arch Pharm Res. 2012 Mar;35(3):565-71.
In course of a screening for small molecules presenting potential anticancer properties, a known monoterpene indole alkaloid named Vallesiachotamine was isolated from the leaves of Palicourea rigida (Rubiaceae) collected in the Brazilian Cerrado. The structure was determined by spectroscopic methods, mainly 1D- and 2D-NMR and its biological activities were investigated on cultured human (SK-MEL-37) melanoma cells. In vitro cytotoxicity was evaluated by the 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The inhibitory concentration (IC(50)) was 14.7 +/- 1.2 muM for 24 h of drug exposure. Flow cytometry analysis revealed that Vallesiachotamine induced G0/G1 arrest and increased the proportion of sub-G1 hypodiploid cells (at 11 muM and 22 muM) and this effect was not dependent on time of incubation. At these concentrations, a typical ladder was observed by agarose gel electrophoresis of the extracted DNA. Treatment of cells with 50 muM Vallesiachotamine for 24 h caused extensive cytotoxicity and necrosis. Our results demonstrated that the indole alkaloid Vallesiachotamine exhibited important cytotoxicity toward human melanoma cells and that apoptosis and necrosis might be responsible for the observed events.